[
  {
    "ts": null,
    "headline": "AbbVie (ABBV) Maintains Immunology Dominance as Analysts Downplay Competitive Threat From J&J’s Tremfya to Skyrizi Market Share",
    "summary": "AbbVie Inc. (NYSE:ABBV) is one of the best stocks for the next decade. On December 12, Morgan Stanley raised the firm’s price target on AbbVie to $269 from $261 with an Overweight rating on the shares. Earlier on December 10, HSBC upgraded AbbVie to Buy from Hold with a price target of $265, which was […]",
    "url": "https://finnhub.io/api/news?id=1a0fa66636fbd5ed091ca0064809eb15a8210d219f65f4c6d1b2ead6db9d097f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767197565,
      "headline": "AbbVie (ABBV) Maintains Immunology Dominance as Analysts Downplay Competitive Threat From J&J’s Tremfya to Skyrizi Market Share",
      "id": 137950172,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie Inc. (NYSE:ABBV) is one of the best stocks for the next decade. On December 12, Morgan Stanley raised the firm’s price target on AbbVie to $269 from $261 with an Overweight rating on the shares. Earlier on December 10, HSBC upgraded AbbVie to Buy from Hold with a price target of $265, which was […]",
      "url": "https://finnhub.io/api/news?id=1a0fa66636fbd5ed091ca0064809eb15a8210d219f65f4c6d1b2ead6db9d097f"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer, GSK Lead U.S. Drugmakers Planning 2026 Price Hikes on 350 Drugs",
    "summary": "List prices to rise an average of 4% despite federal pressure to curb costs.",
    "url": "https://finnhub.io/api/news?id=99a41ad6d5957640fad350a769e0fb968bc194a5106242f6b7878d63c84d7775",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767191682,
      "headline": "Pfizer, GSK Lead U.S. Drugmakers Planning 2026 Price Hikes on 350 Drugs",
      "id": 137950161,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "List prices to rise an average of 4% despite federal pressure to curb costs.",
      "url": "https://finnhub.io/api/news?id=99a41ad6d5957640fad350a769e0fb968bc194a5106242f6b7878d63c84d7775"
    }
  },
  {
    "ts": null,
    "headline": "Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock",
    "summary": "AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=4de930622a81a31b6550b654e68f42109d65c951ae2871b80e1c6d24c7f93f46",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767189608,
      "headline": "Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock",
      "id": 137950207,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=4de930622a81a31b6550b654e68f42109d65c951ae2871b80e1c6d24c7f93f46"
    }
  },
  {
    "ts": null,
    "headline": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings",
    "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
    "url": "https://finnhub.io/api/news?id=d502f4b3d09d6d38381003805b97591464cfa3a2103eec066c7fc7b27aa6fe56",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767189603,
      "headline": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings",
      "id": 137950208,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
      "url": "https://finnhub.io/api/news?id=d502f4b3d09d6d38381003805b97591464cfa3a2103eec066c7fc7b27aa6fe56"
    }
  },
  {
    "ts": null,
    "headline": "Best Dividend Aristocrats For January 2026",
    "summary": "Best Dividend Aristocrats For January 2026",
    "url": "https://finnhub.io/api/news?id=0efd569dae7709ab1787c907709a5e73b4919b4c811f73b8cd583628148221e4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767170878,
      "headline": "Best Dividend Aristocrats For January 2026",
      "id": 137948634,
      "image": "",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=0efd569dae7709ab1787c907709a5e73b4919b4c811f73b8cd583628148221e4"
    }
  }
]